Download Free Making Markets For Vaccines Ideas To Action Brief Book in PDF and EPUB Free Download. You can read online Making Markets For Vaccines Ideas To Action Brief and write the review.

A legacy of our generation -- Ch. 1. We need to invest more in vaccines -- Ch. 2. Promoting private investment in vaccine development -- Ch. 3. A market not a prize -- Ch. 4. Design choices -- Ch. 5. $3 billion per disease -- Ch. 6. Meeting industry requirements -- Ch. 7. How sponsors can do it.
A provocative analysis of market-based interventions into public problems and the consequences. Market-based interventions have been used in attempts to solve numerous public problems, from education to healthcare and from climate change to privacy. Scholars have responded persuasively through critiques of neoliberalism. In Can Markets Solve Problems? Daniel Neyland, Véra Ehrenstein, and Sveta Milyaeva propose a different route forward. There is no single entity knowable as “the market,” the authors argue. Instead, they examine in detail the devices, relations, and practices that underpin these market-based interventions. Drawing on recent work in science and technology studies (STS), each chapter focuses on a different intervention and critically explores the market sensibility around which it is organized. Trade and exchange, competition, property and ownership, and investment and return all become the focus of a thorough exploration of what it means to intervene in public problems, how problems are composed, and how solutions are continually reworked. Can Markets Solve Problems? offers the first book-length STS enquiry into markets and public problems. Weaving together rich empirical descriptions and conceptual discussions, the book provides in-depth insights into the workings of these markets, their continuous evolution, and the consequences. The result is a new avenue of critical inquiry that moves between the details of specific policies and the always-emerging, collective features of this landscape of intervention.
'Short of the Goal' analyses US policy toward poorly performing states that are ineligible for new U.S. foreign assistance programs and examines the role of specific policy instruments in building state capacity to prevent deterioration and collapse.
Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.
This volume examines the economics of the biopharmaceutical industry, with eighteen chapters by health economists.
The White House and the World shows how modest changes in U.S. policies could greatly improve the lives of poor people in developing countries, thus fostering greater stability, security and prosperity globally and at home. Center for Global Development experts offer fresh perspectives and practical advice on trade policy, migration, foreign aid, climate change, and more. In an introductory essay, CGD President Nancy Birdsall explains why and how the next U.S. president must lead in the creation of a better, safer world.
"Economic Development, the leading textbook in this field, provides your students with a complete and balanced introduction to the requisite theory, driving policy issues, and latest research. Todaro and Smith take a policy-oriented approach, presenting economic theory in the context of critical policy debates and country-specific case studies, to show how theory relates to the problems and prospects of developing countries."--Publisher0́9s description
Discussions of the use and limits of randomized control trials, considering the power of theory, external validity, gaps in knowledge, and what issues matter. The practice of development economics has undergone something of a revolution as many economists have adopted new methods to answer perennial questions about the effectiveness of anti-poverty programs. In this book, prominent development economists discuss the use and impact of one of the most significant of these new methods, randomized control trials (RCTs) and field experiments. In extended interviews conducted over a period of several years, they explain their work and their thinking and consider the broader issues of how we learn about the world and how we can change it for the better. These conversations offer specialists and nonspecialists alike a unique opportunity to hear economists speak in their own words, free of the confines of a particular study or econometric esoterica. The economists describe how they apply research findings in the way they think about the world, revealing their ideas about the power of theory, external validity, gaps in knowledge, and what issues matter. Also included are interviews with RCT observers, critics, sponsors, consumers, and others. Each interview provides a brief biography of the interviewee. Thorough annotations offer background and explanations for key ideas and studies referred to in the conversations. Contributors Abhijit Banerjee, Nancy Birdsall, Chris Blattman, Alex Counts, Tyler Cowen, Angus Deaton, Frank DeGiovanni, Esther Duflo, Pascaline Dupas, Xavi Gine, Rachel Glennerster, Judy Gueron, Elie Hassenfeld, Dean Karlan, Michael Kremer, David McKenzie, Jonathan Morduch, Lant Pritchett, Jonathan Robinson, Antoinette Schoar, Dean Yang
In a time when multinational corporations have become truly globalised, demands for global standards on their behaviour are increasingly difficult to dismiss. Work conditions in sweatshops, widespread destruction of the environment, and pharmaceutical trials in third world countries are only the tip of the iceberg. This timely collection of essays addresses the interface between the calls for corporate social responsibility (CSR) and the demands for an extension of international human rights standards. Scholars from a vast variety of backgrounds provide expert yet accessible accounts of questions of law, politics, economics and international relations and how they relate to one another, while also encouraging non-legal perspectives on how businesses operate within and around human rights. The result is an essential incursion for a wide range of scholars, practitioners and students in law, development, business studies and international studies, in this emerging area of human rights.